| Version | Description of change | Author | Effective date |
|---|---|---|---|
| V1.0 | Original publication | Laboratories Branch; Pharmacovigilance and Special Access Branch; Regulatory Guidance Team | March 2017 |
| V1.1 | Updated to clarify content | Pharmacovigilance and Special Access Branch | July 2018 |
| V1.2 | Updated to amend name | Pharmacovigilance and Special Access Branch | May 2019 |
| V1.3 | Minor updates to reflect CTA name change | Biological Science Section | November 2020 |
| V1.4 | Updates to reflect removal of TGO 93 declaration form requirement | Experimental Products Section | November 2021 |
| V1.5 | Updates to take into account the revised TGO 93 (Amendment Order March 2022) | Manufacturing Quality Branch | March 2022 |
Version history
Last updated